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Spleen cells of neonatal mice are capable of suppressing a  variety of immune 
functions (1-12).  Several laboratories have shown that neonatal spleen cells can 
suppress the mixed leukocyte reaction (MLR) 1 between normal adult responder 
cells and allogeneic stimulator cells, regardless of the haplotype of the responder 
or stimulator cells (1-7).  The suppression of a variety of different in vivo assays 
measuring graft vs.  host disease  (GVHD)  has also  been  demonstrated (8-10). 
Similar  types  of nonspecific  suppressor  cells  have  been  described  in  animals 
treated with total lymphoid irradiation (TLI) (13), in early aUogeneic radiation 
chimeras (14), and in irradiated animals repopulated with syngeneic bone marrow 
(15).  Recent  studies  (16)  suggest  that  these  naturally  occurring  nonspecific 
suppressor cells may regulate the generation of antigen-specific suppressor cells, 
which maintain tolerance to foreign allografts. 
Although the presence of nonspecific suppressor cells in the spleen of neonates 
has been generally accepted, the surface phenotype has been debated.  Argyris 
(1, 2) reported that treatment of neonatal spleen cells with anti-Thy-1.2 antiserum 
and complement abrogated  the ability of neonatal cells to suppress  the  MLR, 
and concluded that the suppressor cell was of T  cell origin. Rodriguez et al. (3) 
used similar negative selection techniques and treated neonatal spleen cells with 
a  variety of antibodies and complement. The latter investigators characterized 
the neonatal cell capable of suppressing the MLR as a null cell (neither T  nor B 
cell). Furthermore, these authors found that purified neonatal T  cells possessed 
normal reactivity in the  MLR, and that neonatal spleen cells from nude mice 
could also suppress the MLR (3). Peeler et al. (4) used velocity sedimentation to 
isolate suppressor cells from the neonatal spleen that were histologically charac- 
terized  as  macrophages  and  mast  cells.  Oseroff et  al.  (5)  used  the  panning 
technique  in  an  attempt  to  characterize  the  neonatal  suppressor  cell.  These 
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authors  found  that neonatal  cells positively selected with antibodies against the 
Thy-l.2,  Ig,  MAC-l,  or F4/80  surface markers did  not  suppress an  MLR,  but 
that  negatively  selected  cells  suppressed  as  well  as  unfractionated  cells.  The 
results  indicated  that  the  neonatal  suppressor  cells  resided  in  the  null  cell 
population. 
We report here the development of long-term cloned cell lines derived from 
the neonatal  spleen that maintain suppressive activity in the  MLR.  The experi- 
mental data suggest that these cloned natural suppressor (NS) cells have a unique 
regulatory function and surface phenotype. 
Materials and  Methods 
Animals.  BALB/c (H-2a), C57BL/Ka (H-2b), and Swiss/nude mice were obtained from 
the specific pathogen-free colony of Robert Kallman, Department of Radiology, Stanford 
University, Palo Alto,  CA.  BALB/c neonates,  1-3 d  old, were obtained from the same 
source.  A/J (H-2  a) mice were a  kind  gift of C.  G.  Fathman,  Department of Medicine, 
Stanford University. DBA/2  (H-2  d) mice were purchased from Sirnonsen  Laboratories, 
Inc. (Gilroy, CA). C3H/HeJ (H-2  ~) mice, 5-8 wk old, were purchased from The Jackson 
Laboratories (Bar Harbor, ME).  Mice used in experiments were housed in conventional 
animal facilities and were 6-10 wk of age. Male Lewis rats, 8-10 wk old, were purchased 
from Simonsen Laboratories, Inc. 
Preparation of Spleen Cells.  Single-cell suspensions of spleen cells were prepared using 
a sterile technique. Upon removal, spleens were gently pressed through nylon fiber mesh 
(Tetko,  Inc.,  Elmsford, NY) then  centrifuged and  resuspended  in  RPMI-1640 (Gibco, 
Grand  Island,  NY).  Cells  were  counted  and  viability determined  by trypan  blue  dye 
exclusion. 
MLR Suppressor Assay.  Irradiated (3,000  rad) cloned cell lines (control or NS cells) 
were added at a variety of concentrations to 96-weU, flat-bottom microtiter plates (Costar, 
Cambridge, MA) containing 5 X 105 responder spleen cells and 5 x  105 irradiated (3,000 
rad) stimulator spleen cells/well in  a  final volume of 300 ul.  Stimulator and cocultured 
cells were irradiated in a  l~VCs irradiator (Mark  1 Model 25  Irradiator; J.  L.  Shepherd 
and Associates, Glendale, CA). MLR media consisted of RPMI-1640,  10% human serum 
(Biocell  Laboratories, Carson City, CA),  5  x  10 -5 M  2-mercaptoethanol (2-ME),  2 rnM 
glutamine,  100  U/ml  penicillin,  and  100  ug/ml  streptomycin  (PSG),  all  from  Gibco. 
Cultures were incubated at  37°C in a humidified atmosphere of 5%  CO2  in air. After 
120 h, plates were pulsed with 1 ~Ci/well [~H]thymidine (sp act 6.7 Ci/mM; New England 
Nuclear, Boston, MA). After 18 h, the plates were harvested onto glass fiber filter papers 
(Whatman,  Inc., Clifton, N  J) by means of a  multiple automated sample harvester (Bio- 
Plastics,  Redwood City, CA).  The dried paper disks were placed into vials containing 2 
ml scintillation cocktail (Betafluor; National Diagnostics, Somerville, N  J) and incorporated 
radioactvity was measured in  a  liquid  scintillation counter (Beckman Instruments,  Inc., 
Fullerton,  CA).  The  data  was  expressed  as  the  mean  of triplicate  cultures.  Percent 
suppression was calculated as: [1  -  (cpm with cocultured cells)/(cpm without cocultured 
cells)] x  100. 
Preparation  of Concanavalin A-stimulated  Rat Spleen  Cell Supernatants (CAS).  Lectin- 
free supernatants from concanavalin A-stimulated Lewis rat spleen cells were prepared 
as previously described by Oseroff et al. (5). 
Cell Lines.  The HT-2 cell line (17),  an interleukin  2 (IL-2)-dependent T  cell line of 
BALB/c origin  was obtained from C.  G.  Fathman,  Department of Medicine,  Stanford 
University, and  maintained in  RPMI-1640  media containing  15%  CAS,  10%  fetal calf 
serum (FCS)  (Hyclone, Logan, UT), 2-ME, and PSG. The 4.1.12  T  cell clone, which is 
an A/J anti-C57BL/Ka-reactive helper cell line was obtained from C. G. Fathman. These 
cells were periodically divided and propagated by adding 106 T cells to 5.0 X 107 irradiated 
C57BL/Ka spleen cells in RPMI-1640 with 10% FCS, 2-ME, PSG, and 1% CAS. The 5.2 
cloned  T  cell  line,  a  BALB/c  line  reactive against  ovalbumin,  was obtained  from C. SCHWADRON  ET  AL.  299 
Janeway,  Department  of Pathology, Yale  University.  The  5.2  cell line was periodically 
propagated  by adding  I06  T  cells  to  2.0  ×  107  irradiated  BALB/c spleen  cells,  with 
ovalbumin, in Click's medium plus 10% CAS. The YAC-1 and EL4 tumor cell lines were 
obtained  from  I.  L.  Weissman,  Department  of Pathology,  Stanford  University,  and 
maintained in RPMI-1640 with  10% FCS, 2-ME, and PSG. 
Antibodies.  Monoclonal rat anti-mouse antibodies specific for Lyt-1 (clone 53-7.3) and 
Lyt-2 (53-6.7) were obtained from Becton-Dickinson, Inc. (Sunnyvale, CA). Monoclonal 
rat anti-mouse antibody against  Ly-5 (M  1/9.3HL)  was purchased  from Hybritech (San 
Diego, CA). Ly-5 (CLA-T200) is found on all leukocytes (18). Monoclonal rat anti-mouse 
antibody against MAC-1 was provided by J.  Monaco, Department of Medical  Microbiol- 
ogy, Stanford University. Monoclonal rat anti-mouse antibody against Thy-l.2 (clone 30- 
H 12) was obtained from I. L. Weissman, Department of Pathology, Stanford University. 
Monoclonal rat anti-mouse idiotypic antibody, used as an irrelevant control, was obtained 
from R.  Levy, Department of Medicine, Stanford University. Fluoresceinated goat anti- 
rat  Ig (FITC-GAR), which was absorbed to have no crossreactivity with mouse  Ig, was 
purchased from Capell Laboratories (Cocbranville, PA). FITC-GAR was used as a second 
antibody for previously mentioned rat anti-mouse monoclonal antibodies, which were not 
fluoresceinated.  Rabbit anti-mouse  Ig antiserum  was prepared  as described  previously 
(19). Rabbit anti-asialo GM1 antiserum was purchased from Wako Chemicals USA, Inc. 
(Dallas, TX).  Fluoresceinated  goat anti-rabbit  Ig, used as a  second stage for the above- 
mentioned rabbit antibodies, was purchased from Capell Laboratories. Specifically eluted 
rabbit  anti-keyhole  limpet  hemocyanin antibodies  were  used  as control antibodies  for 
staining  with  rabbit-derived  antibodies  (19).  Monoclonal  mouse anti-IE  d (clone  14.4.4) 
antibody  was  obtained  from  H.  O.  McDevitt,  Department  of Medical  Microbiology, 
Stanford University, and conjugated to fluorescein by a standard protocol (20).  Directly 
fluoresceinated  mouse  anti-human  Leu-3  antibody  (Becton-Dickinson)  was  used  as  a 
control for staining with fluoresceinated mouse anti-IE  d. 
Immunofluorescent  Staining and Fluorescence-activated Cell Sorter (FA CS) Analysis.  Spleen 
cells were treated to lyse red cells (0.155  M  NH4CI, 0.1  M  KHCO3, and 0.1  mM EDTA 
in distilled water, pH 7.4), or purified by density gradient centrifugation on Lympholyte- 
M (Cederlane Labs, Ontario, Canada) before use for staining. The entire staining proce- 
dure was performed at 4°C.  Indirect staining was performed  using a  modification of a 
two-stage procedure described previously (5).  All antibodies were used at a concentration 
previously shown to be at the saturation point for staining. Staining with directly fluores- 
cinated antibodies was performed in a  similar manner, except the second stage was not 
used. 
The stained cells were analyzed on a FACS III (Becton Dickinson) that was coupled to 
a  PDP-1 1 computer.  Scatter gates were set to exclude residual erythrocytes, dead cells, 
and aggregates.  Light scatter  and autofluorescence  were determined  on unstained  but 
identically manipulated cells. Staining controls included cells stained with irrelevant first- 
stage antibodies.  In general, integration of antibody staining curves to determine percent 
positivity were performed at the point where background staining with irrelevant antibody 
was ~2%. 
Mycoplasma  Testing.  Cell  lines were examined for the presence of mycoplasma using 
the technique described by Chen (21). In essence, supernatants from cell lines to be tested 
for mycoplasma were first  incubated  with  the  3T3  (22)  mycoplasma-free indicator cell 
line. The indicator cells were then stained with Hoechst 33258 reagent, which detects the 
presence  of mycoplasma  DNA  on  the  surface  of indicator  cells  incubated  with  test 
supernatants. All cell lines used in this paper were mycoplasma negative at all times tested. 
Natural  Killer  (NK) Assay.  The  NK  assay  against  the  YAC-1  tumor  cell  line  was 
performed as previously described (5).  In this assay,  104 5'Cr-labeled YAC-1  cells were 
incubated for 4-6 h  with effector cells at a variety of different effector/target cell ratios. 
Supernatants were harvested and counted on a gamma counter (Biogamma II, Beckman 
Instruments, Inc.). Percent specific lysis was calculated according to the formula: percent 
specific lysis =  [(cpm experimental) -  (cpm spontaneous release)] ×  100/[(cpm maximum 300  CLONED  NATURAL SUPPRESSOR  LINES FROM  NEONATAL MICE 
release)  -  (cpm  spontaneous  release)].  Swiss  nude  mouse  spleen  cells  were  used  as  a 
positive control. 
Proliferation of HT-2  Cells in  Response to IL-2.  The  HT-2  cell  line  can  be  used  to 
measure the presence of IL°2 in test supernatants (23).  For this purpose, 2  x  104 HT-2 
cells/well were plated into 96-well microtiter plates in media consisting of RPMI-1640, 5 
×  10  -5  M  2-ME,  10%  FCS,  and  PSG.  Various  dilutions  of a  control  IL-2-containing 
supernatant  were added,  as were similar  dilutions  of supernatants  to be tested  for the 
presence of IL-2. After 20 h, the cultures were pulsed with [~H]thymidine, then harvested 
six h later and counted as described for the MLR. Assays for suppression of [3H]thymidine 
uptake by various irradiated  cocultured cells was performed using the same procedure, 
except  that  a  constant  source of IL-2 (20%  CAS) was added,  and  various numbers  of 
irradiated cocultured cells were added per well. 
Fc and C3 Receptor Assay.  The assays for detecting Fc and C3 receptors on the surface 
of NS and control cells were performed as previously described (24). 
Thymocyte Proliferation Assay.  The  thymoc~cte proliferation  assay was performed  ac- 
cording to the protocol described by Mizel (25). Thymus cells of C3H/HeJ mice (5-8 wk 
old) were plated into microtiter plates at 1.5 ×  106 cells/well in media consisting of RPMI- 
1640,  10%  FCS,  2-ME,  PSG, and phytohemagglutinin  (PHA) (1.25  #g/ml) (Wellcome 
Research  Laboratories,  Beckenham, Great  Britain).  In assays measuring the potency of 
1L-1 preparations,  the supernatants to be tested were added at various dilutions. After 3 
d,  cultures  were  pulsed  with  0.5  t~Ci/well  [~H]thymidine  (as  used  in  the  MLR)  and 
harvested 6 h later. 
IL-1 Production Suppressor Assay.  Peritoneal exudate cells (PEC) or resident peritoneal 
macrophages  from  BALB/c  mice  were  tested  for  the  ability  to  produce  IL-1  in  the 
presence of NS cells,  control cells,  or in  the absence  of added  coculture cells.  PEC  or 
resident  macrophages were plated  into 24-well plates (Costar) at a  density of 106 cells/ 
well in media consisting of RPMI-1640,  10% FCS, and PSG. After 2 h, the nonadherent 
cells  were  removed  by  vigorous washing.  The  adherent  cells  were  then  incubated  in 
"induction"  media,  which  consisted  of RPMI-1640,  5%  FCS,  PSG,  lipopolysaccharide 
(LPS) (I 0 gg/ml) (Difco, Detroit,  MI) and indomethacin (7 #g/ml) (Sigma Chemical Co., 
St. Louis, MO). At this point, graded numbers of irradiated NS cells, control cells, or no 
cells were added to the cultures.  After 24 h,  the supernatants  were removed, dialyzed, 
sterilized, and tested for IL-1 activity in the thymocyte proliferation assay (as described). 
Supernatants were tested in the HT-2 assay to confirm the absence of IL-2 activity. 
Establishment of NeonataUy Derived NS Cell Lines.  Neonatally derived NS cell lines were 
established using a modification of the procedure described by Oseroff et al. (5).  Spleen 
cells were obtained from BALB/c pups <3 d old, and prepared as single cell suspension 
in culture media consisting of RPMI-1640, 10% FCS, 5 ×  10  -5 M 2-ME, 2 mM glutamine, 
100  U/ml  penicillin,  I00 ~g/ml streptomycin, and  5 #g/ml concanavalin A  (Pharmacia 
Fine Chemicals, Piscataway, N  J). Neonatal cells (5 ×  106 cells/well) were added to 24-well 
plates (Costar) in  1 ml/well.  After 3-6 d, this medium was changed by gentle aspiration 
with a  transfer pipet.  Cells were then fed with  RPMI-1640,  10%  FCS, 2-ME,  PSG, and 
30%  CAS.  Medium  was changed daily by gentle aspiration  and  replacement  with fresh 
medium. Irradiated feeder cells (BALB/c adult spleen; 3,000 rad) were added on a weekly 
basis, until healthy proliferating cultures were established.  After the first 6 wk, addition 
of feeder ceils was no longer necessary. Initially, several different types of adherent and 
nonadherent cells were seen in culture, similar to those reported by Oseroff et al. (5) in 
the establishment of NS cell lines derived from mice treated with TLI. After ~6-8 wk in 
culture, a predominant cell type arose. These cells were of medium size, and were mildly 
adherent  to plastic.  At this point,  the predominant proliferating cells were transferred 
from 24-well plates to 25 cm  2 flasks (Corning Glass Works, Corning, NY). Cells established 
with this procedure have been in culture for >1  yr. These cells were highly suppressive 
when  added  to the  MLR at  all  time  points tested  (see  Results).  The  cells  continue  to 
require daily feeding with fresh media containing  10-15% CAS, and die within  several 
days after removal of CAS from the tissue culture medium. 
Initially,  four uncloned,  neonatally  derived  NS cell  lines  were established  using this SCHWADRON  ET  AL.  301 
protocol. After 5 mo, one uncloned cell line (N4B) was cloned by limiting dilutions in 96- 
well microtiter plates (0.3  cells/well)  using a  protocol described by Hertei-Wulff et al. 
(26). All cell lines were tested for mycoplasma contamination using the method of Chen 
(21) and found to be free of detectable levels of mycoplasma. 
Results 
Suppression of MLR.  Aliquots  of fresh  neonatal  spleen  cells  from  BALB/c 
pups <3 d old were tested for suppressive activity in the MLR. In a representative 
experiment (Fig.  1 A), addition of irradiated (3,000 rad in vitro) neonatal spleen 
ceils, at a  1:1  ratio to adult responder cells, resulted in 75%  suppression of the 
MLR compared to that observed without cocultured ceils. Addition of irradiated 
adult spleen  cells produced  minimal suppression  as compared  to  the  neonatal 
cells (Fig.  1 A). 
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FIGURE  1.  (A) Suppression of the MLR after addition of fresh BALB/c neonatal (<3 d  old) 
spleen cells. The BALB/c vs. C57BL/Ka MLR assay was performed and results evaluated as 
described  for  B.  Graded  numbers  of irradiated  BALB/c  neonatal  spleen  cells  (H)  or 
irradiated adult (2 mo old) BALB/c spleen cells (E]-----D)  were added to the MLR. BALB/c vs. 
C57BL/Ka cultures without cocultured cells gave 69,200  +  978  cpm.  BALB/c vs.  BALB/c 
cultures gave 3,066_+  643 cpm. A  representative experiment is depicted. (B) Suppression of 
the MLR after the addition of uncloned natural suppressor (NS) cells derived from the spleen 
of BALB/c neonatal mice. Graded numbers of irradiated (3,000 rad) NS cells or irradiated 
HT-2 cells were added to a  BALB/c vs. C57BL/Ka MLR with 5 ×  105 responder cells and 5 
×  105 irradiated (3,000 rad) stimulator cells/well. Cultures were pulsed with [3H]thymidine on 
day 5, and harvested 18 h later. (H),  N4B (uncloned NS cell line): (O-----O), HT-2 (a cloned 
BALB/c T  cell line).  Percent suppression is calculated as [1  -  (cpm with cocuhured cells)/ 
(cpm without cocuhured cells)] x  100.  BALB/c vs.  C57BL/Ka cultures without cocuhured 
cells gave 149,000 _+ 8,997 cpm. BALB/c vs. BALB/c cultures gave 2,680 _+ 320 cpm. Results 
are given as the mean -4- SE of triplicate cultures. A representative experiment is shown. 302  CLONED  NATURAL  SUPPRESSOR  LINES  FROM  NEONATAL  MICE 
Initially, four  uncloned natural  suppressor  (NS)  cell  lines  were  established 
from four different groups of neonatal BALB/c pups, as described in Materials 
and Methods. There was an initial paucity of cells until the emergence of rapid 
cell growth at  ~2  mo after the initiation of cell culture. Thus,  2  mo was the 
earliest time at which suppressive activity was tested in the MLR. Fig. 1 B shows 
an  experiment in  which  the  N4B  uncloned cell  line (irradiated in  vitro  with 
3,000 rad) was added to a BALB/c vs. C57BL/Ka MLR after in vitro culture for 
2-4 mo. Even at a suppressor/responder ratio of 1:50, almost 100% suppression 
of the  MLR  is  seen.  The  BALB/c cloned  T  cell  line,  HT-2,  was  used  as  a 
cocuhured cell control in this experiment, since these cells, as well as the NS ceils 
are dependent upon the addition of CAS to the culture medium for continued 
growth.  Although  23%  suppression  was  observed  with  105  HT-2  cells/well, 
minimal suppression was observed at lower cell doses. The N4B line was highly 
suppressive at these lower doses (Fig.  1  B). 
After the N4B cell line had been in culture for ~5 mo, cloning was performed 
using limiting-dilution techniques (see Materials and Methods). Six cloned long- 
term cell lines were derived from the N4B cell line, and all suppressed the MLR. 
Each of the two cloned NS cell  lines showing greatest suppression upon initial 
examination in the MLR were further examined in 12 separate MLR assays. Fig. 
2 is representative of eight experiments in which the 4BA4 cloned NS cell  line 
was added to syngeneic responder cells (BALB/c) in the MLR. Marked suppres- 
sion (98%) of the MLR is seen when 104 4BA4 cells were added. The suppression 
of the MLR starts to taper offwhen <104 cells/well are added. The HT-2 control 
cell line (104 cells/well) exhibited no suppression, and actually enhanced [3H]- 
thymidine uptake in this particular assay. The 4BA4 and 4BC9 cloned NS cell 
lines  were  tested  in  four  separate  MLR  assays  in  which  the  NS  cells  were 
allogeneic to the responder cell population (C5BL/Ka vs. DBA/2 or C57BL/Ka 
vs. BALB/c). In one representative experiment, 104 4BA4 and 4BC9, cloned NS 
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FIGURE  2.  Suppression of the BALB/c vs. C57BL/Ka MLR after the addition of neonatally 
derived  cloned  BALB/c  NS  cell  lines.  The  MLR  was  performed and  results  evaluated  as 
described in Fig.  1. Graded numbers of irradiated 4BA4 (~---Q), a neonatally derived cloned 
NS cell line; 4BC9 (O--O), a neonatally derived cloned NS cell line; or HT-2 (A--A), a BALB/ 
c cloned T  cell line cells were added to the MLR.  BALB/c vs. C57BL/Ka  cultures without 
cocuhured cells gave 48,357  +  4,797 cpm. BALB/c vs. BALB/c cultures resulted in 3,607  + 
370 cpm. A  representative experiment is depicted. SCHWADRON  ET  AL.  303 
cells showed a  mean of 96%  and 82%  suppression, respectively. In this experi- 
ment, enhancement of the MLR response was seen when  104  HT-2 cells  were 
added. These results demonstrate that the cloned suppressor cell lines suppress 
the MLR regardless of whether the H-2  haplotype is  matched or mismatched 
with  the  responder  or  stimulator cell  population.  In  all  12  MLR assays,  the 
addition of 10 4 4BA4 cells/well gave a  mean suppression of 94%, as compared 
to 3% suppression with the addition of 10 4 control cultured cells (HT-2 cells, or 
the A/J T  cell clone, 4.1.12). 
HT-2 Proliferation  in the Presence  of NS Cells.  Possible mechanisms whereby 
the cloned neonatal NS cell lines could be suppressing the MLR include nonspe- 
cific inhibition of the uptake of [~H]thymidine, or absorption of IL-2 from the 
culture medium. To examine these possibilities, various doses of irradiated 4BA4 
or 4BC9 cell lines were added to a fixed number of HT-2 cells in the presence 
of a  source of IL-2 (CAS).  The HT-2 cell line is derived from a  helper T  cell 
line of BALB/c origin which proliferates in response to IL-2 (17).  As shown in 
Fig. 3, there is only a small difference in suppression of the [~H]thymidine uptake 
of HT-2 cells seen when the 4BA4 or 4BC9 cell lines are added, in comparison 
to the suppression  seen  in  the presence  of irradiated control cocuhured cells 
(BALB/c T  helper cells reactive against ovalbumin, the 5.2 cell line). To deter- 
mine whether cloned NS cells can inhibit proliferation of HT-2 cells when IL-2 
is present in suboptimal quantities,  104  irradiated 4BA4 cells  were added to a 
fixed number of HT-2 cells in the presence of various dilutions of CAS. In three 
separate assays, a  full dose-response curve was plotted using the [3H]thymidine 
uptake  of HT-2  cells  incubated in  serial  twofold dilutions of CAS,  with and 
without 4BA4 cells. Addition of the 4BA4 cells altered the curve minimally (shift 
of less than one twofold dilution) in all assays (data not shown). However, >90% 
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FIGURE  3.  The effect of cloned NS cell lines on [ H]thymidine incorporation by proliferating 
HT-2 cells.  Graded numbers of irradiated 4BA4 (H),  a neonatally derived cloned BALB/ 
c NS cell line; 4BC9 (O---(3), a neonatally derived cloned BALB/c NS cell line; or 5.2 (H), 
a BALB/c T  helper cell line cells were added to HT-2 cells (2 x  104 cells/well) in the presence 
of 15%  CAS. Cultures were pulsed with [SH]thymidine 20 h after the initiation of the assay, 
and  harvested 6  h  later.  Percent suppression was  calculated by  comparing [SH]thymidine 
uptake  without cocultured  cells  to  that  seen  with  cocuhured  cells.  HT-2  cultures  in  the 
presence of IL-2 gave 81,874 _-_ 3,354 cpm. A representative experiment is shown. 304  CLONED  NATURAL  SUPPRESSOR  LINES  FROM  NEONATAL  MICE 
suppression of the MLR was observed with the addition of similar numbers of 
cloned NS cells (Fig. 2). 
We also examined the ability of irradiated HT-2 vs. irradiated 4BA4 NS cells 
to absorb  IL-2 from the culture media.  Irradiated HT-2  or  4BA4  cells  were 
plated into 96-well microtiter plates at a density of 105 or 104 cells/well in media 
containing 20% CAS. After 24 h, the supernatants were removed and tested for 
IL-2 activity in the HT-2 assay, as shown in Fig. 4.  While l0 p irradiated HT-2 
or  4BA4  absorbed  substantial quantities of IL-2  from the culture media,  104 
irradiated HT-2 or 4BA4 did not absorb sufficient IL-2 from the culture media 
to  alter  the  dilution  curve  compared  to  unabsorbed  control  CAS-containing 
media. Thus, at cell numbers where NS cells suppress the MLR by almost 100%, 
and HT-2 cells show little or no suppression of the MLR (104 cells/well), both of 
these  cell  lines  absorbed  little  or  no  IL-2  from  the  culture  media.  These 
experiments demonstrate that nonspecific inhibition of [3H]thymidine uptake or 
absorption of the IL-2 does not explain the suppression of the MLR by cloned 
NS cells. 
Effect of NS Cells on IL-1 Production.  Graded numbers of irradiated NS cells 
or  HT-2  cells  were  added to  resident peritoneal  macrophages  or  peritoneal 
exudate macrophages to assess the effect on IL-1 production, Supernatants were 
collected from PEC or resident macrophages that were induced to produce IL- 
l  (as described in Materials and Methods) in the presence or absence of cocul- 
tured cells, and the supernatants were tested in the thymocyte proliferation assay 
to detect the presence of IL-1. All supernatants were also tested in the HT-2 
assay,  and  had  no  detectable  IL-2  activity.  The  data  presented  in  Table  I 
demonstrates that the addition of 4BA4 NS cells  to resident peritoneal macro- 
phages does not interfere with the ability of these cells  to produce IL-1  after 
stimulation with LPS. Essentially identical results were obtained with PEC (data 
not shown). Table I also shows that NS cells do not produce I L-1 under conditions 
in which macrophages are induced to produce IL-1. 
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FTGURE 4.  The ability of NS cells and HT-2 cells to absorb IL-2. Irradiated 4BA4 NS cells 
or HT-2 cells were plated into microtiter wells at a density of 104 or 105 cells/well in media 
containing 20% CAS. 24 h later, the supernatants were harvested and tested for the presence 
of IL-2 in the HT-2 assay.  (O---O),  unabsorbed CAS; (O----O), CAS absorbed by  104  4BA4 
cells;  (A--A), CAS absorbed by  104  HT-2 cells;  (H),  CAS absorbed by  105  4BA4 cells; 
(ffF--CI), CAS absorbed by 105 HT-2 cells. SCHWADRON  ET  AL.  305 
TABLE.  I 
Effect of NS Cells on IL-I Production by Resident Peritoneal 
Macrophages (RPM)* 
Culture conditions  [SH]Thymidine uptake* 
RPM plus LPS  8,921 -  602 
RPM alone  650 ±  135 
RPM plus LPS and 105 4BA4  13,339 ±  1,023 
RPM plus LPS and 104 4BA4  10,320 -  174 
RPM plus LPS and l0 s 4BA4  9,037 + 615 
RPM plus LPS and 105 HT-2  10,529 ± 659 
RPM plus LPS and 104 HT-2  9,447 ± 510 
RPM plus LPS and 103 HT-2  11,393 ± 888 
105 4BA4 plus LPS  766 + 65 
105 4BA4  413 ± 41 
10  ~ HT-2 plus LPS  943 ±  122 
105HT-2  441 ±54 
RPM plus 105 4BA4  660--- 116 
Medium plus LPS  845 -  22 
* RPM, resident peritoneal macrophage. 
* [SH]Thymidine uptake  by C3H/HeJ thymocytes incubated  in a  10% 
solution of the given supernatant,  in ,the presence of PHA; cpm + SE. 
Surface Phenotype of Cloned NS Cells..  The cell surface phenotype of the 4BA4 
cloned  cell  line  was  determined  after' staining  with  a  panel  of antibodies  and 
analysis on the F~CS III. Table II shows representative staining results of several 
different  experiments.  The  cells  stained  brightly  with  anti-Thy-l.2,  anti-Ly-5, 
and anti-asialo  GM 1 antibodies.  However, the staining was essentially negative 
for surface Ig and I-E, Lyt-1, Lyt-2, and MAC-1  surface antigens. The uncloned 
parental cell line N4B (from which 4BA4 was cloned) showed an identical staining 
profile when first assayed, ~2 mo after the initiation of culture. 
The  4BA4  and  4BC9  cell  lines  were  tested  for  the  presence  of the  Ig  Fc 
fragment receptor (FcR) and the complement (C3) receptor. Rosette assays were 
performed using sheep red blood cells (SRBC) coated with hyperimmune mouse 
anti SRBC antiserum (IgG-EA), or SRBC coated with rabbit IgM anti-SRBC plus 
AKR  mouse  serum,  which  included  complement  (IgM-EAC).  The  4BA4  and 
4BC9  cell  lines did  not  form rosettes with  SRBC,  IgM-EA,  IgM-EAC,  or  IgG- 
EA. Thus, neither line expressed Fc or C3 receptors. The P388D1  macrophage 
tumor cell line (27) was used as a  positive control.  The latter cells formed 92% 
rosettes with IgG-EA and 64% with IgM-EAC in a representative experiment. 
Assay for NK Activity.  In view of the similarities between the staining pattern 
of the cloned neonatal suppressor cell lines with that reported for cloned murine 
NK cells (28),  the  4BA4  cloned  NS  line  was tested  for  NK activity against the 
NK-sensitive YAC-1  tumor cell line.  Several laboratories  with established  long- 
term NK cell lines report vigorous lysis of the YAC-1  cell line by cloned NK cell 
lines  (28-30).  Fig.  5  shows  the  results  representative  of five  experiments,  in 306  CLONED  NATURAL  SUPPRESSOR  LINES  FROM  NEONATAL  MICE 
TABLE  II 
Surface Phenotype of the NeonataUy Derived Cloned 4BA4 NS 
Cell Line 
Antibodies used for staining 
Positively stained cells* 
4BA4  BALB/c adult 
spleen cells 
% 
Anti-Thy-l.2  88 +  6  43 -  9 
Anti-Lyt-1  1 4- 1  26 +  2 
Anti-Lyt-2  2  -+ 2  15 -  3 
Anti-lg  4  -  3  40 4- 10 
Anti-lE  4  4- 1  ND  $ 
Anti-MAC-1  1 --- 1  ND  ~ 
Anti-Ly-5  88 4- 7  87 +  3 
Anti-asialo-GM 1  72 4- 11  ND I 
*  Mean  +  SE  positive  cells  above  background  fluorescence  for  3-6 
separate experiments. 
$ ND,  not done.  BCLsb, a  B  cell  leukemia cell  line,  stained 84  _  10% 
positive. 
§ P388D1, a  macrophage tumor cell line, stained 72 +  11% positive. 
JI Swiss nude spleen cells stained 45 +  2% positive. 
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FIGURE  5.  Percent  specific  lysis of  S~Cr-labeled  YAC-1  cells  (10 4  cells/well)  after  a  4-h 
incubation with different numbers of effector cells. (H),  4BA4 neonatally derived  NS cell 
line; (A--A), Swiss nude spleen cells. 
which the 4BA4 cell line showed no lysis of YAC-1 target cells above background. 
Similar results  were  obtained  when  the  uncloned parental  N4B  cell  line was 
tested for NK activity. 
Discussion 
In  recent  years,  investigators  have  demonstrated  (1-12)  the  existence  of 
nonspecific suppressor  cells  in  the  neonatal  mouse spleen  that  inhibit T  cell 
alloreactivity and a variety of other immune functions. In this paper, we describe 
the establishment and characterization of cloned NS cell lines derived from the 
spleen of neonatal BALB/c mice. Irradiated cloned NS cells suppress the MLR 
between  normal  adult  responder  and  stimulator cells  with  a  50-fold  greater SCHWADRON  ET  AL.  307 
efficacy than  irradiated  fresh neonatal  spleen cells.  Both fresh neonatal  spleen 
cells and cloned NS cells suppress the MLR regardless of the H-2 haplotype of 
the responder or stimulator cell. Cloned NS cells show 80-100% suppression of 
the MLR over a  range  of cell doses in which control T  ceil lines derived from 
BALB/c and other strains show little or no suppression. 
Continued  growth of the cloned NS cells is dependent upon the addition  of 
supernatants  of concanavalin  A-stimulated rat spleen cells (CAS) to the culture 
medium.  NS cells die within several days after the removal of CAS. Preliminary 
experiments indicate that  substitution of recombinant  IL-3 (kindly supplied by 
DNAX Research Institute,  Paio Alto, CA) for CAS is not sufficient to support 
growth of cloned NS cells. However, the substitution of partially purified human 
IL-2 (Collaborative Research, Lexington, MA) does support the growth of cloned 
NS cells (R. Schwadron, unpublished observations). 
We routinely tested all  cell  lines described in  this paper  for the presence of 
mycoplasma contamination  (as described in Materials and Methods), and all cell 
lines were found to be mycoplasma-free.  In addition,  cloned NS cells were also 
tested  by the  University  of California,  San  Francisco  cell  culture  facility and 
found to be mycoplasma-free in three  independent  tests.  Thus,  negative  serial 
assays  for  mycoplasma  indicate  that  the  cloned  NS  ceils  and  their  uncloned 
parental cells never contained detectable mycoplasma during any time from their 
initial inception to the present. 
Cloned  NS cells did not significantly inhibit  [~H]thymidine uptake by prolif- 
erating  HT-2  cells,  compared  to  control  cocultured  cells.  This  suggests  that 
interference with [3H]thymidine  uptake per se can not explain  the suppression 
of the MLR. Furthermore,  experiments in which cloned NS ceils were added to 
HT-2 cells in various dilutions of CAS indicate that cloned NS cells do not inhibit 
proliferation of activated T  cells in response to IL-2. The latter experiments also 
indicate  that  doses of NS  cells  (10 4)  that  inhibit  the  MLR  do  not  absorb  or 
consume sufficient IL-2 to change the dilution curve in the HT-2 assay. Experi- 
ments examining the ability of irradiated  NS cells and irradiated  HT-2 cells to 
consume IL-2 from culture  media during a  24-h interval  demonstrate  little or 
no difference in IL-2 consumption. Thus, IL-2 absorption or consumption cannot 
explain  the ability of NS cells to suppress the  MLR when  similar  numbers  of 
HT-2 cells cannot. 
The addition of cloned NS cells does not interfere with the ability of peritoneal 
macrophages  (thioglycolate-stimulated  or resident)  to produce  IL-1.  However, 
the addition of cloned NS cells results in vigorous suppression of the MLR. Since 
the number of cells used (_ 104) does not prevent IL-1 secretion by macrophages, 
nor  interferes  with  T  cell  (HT-2  cell) proliferation  in  response  to  IL-2,  it  is 
tempting  to  speculate  that  suppression  of the  MLR is  related  to  interference 
with early stages oft  cell activation. In particular, NS cells may suppress secretion 
of IL-2 and/or the induction of IL-2 receptors during T  cell activation. 
Immunofluorescence staining and FACS analysis revealed that cloned NS cells 
were strongly positive for the cell surface antigens Thy-l.2,  Ly-5 (CLA T200), 
and asialo-GM 1. NS cells did not express detectable surface Ig, MAC-l, IE, Lyt- 
1, or Lyt-2 surface antigens, nor Fc or C3 receptors.  Although the NS cells are 
strongly positive for Thy-l.2,  the absence of Lyt-I  and  Lyt-2 antigens  on  the 308  CLONED  NATURAL SUPPRESSOR LINES FROM NEONATAL MICE 
cloned NS cell lines and the parental line indicates that these cells are not mature 
T  cells. The absence of surface Ig, MAC-1 antigen, and Fc or C3 receptors, and 
the presence of Thy-l.2 antigen  argues against a  macrophage,  monocyte, or B 
cell origin for cloned NS cells. 
The  surface  phenotype  of the  cloned  NS  cells  is  similar  to  that  reported 
previously for cloned NK cell lines (28, 31). However, NS cells did not lyse 51Cr- 
labeled YAC-1  target  cells.  In  contrast,  vigorous lysis  of these  target  cells has 
been reported for cloned NK cell lines (28-30). 
The  in  vivo  function  of the  cloned  NS  cells  and  their  relationship  to  the 
suppressor cells found in  the fresh neonatal  spleen await further  investigation. 
We have preliminary evidence that cloned NS cells can suppress in vivo GVHD 
in neonates, as measured by the spleen enlargement assay of Simonsen (32) (work 
in progress).  Tbe relationship  to the fresh neonatal suppressor cell(s)  is compli- 
cated by the controversy surrounding the nature of these cells. Various authors 
have concluded that the neonatal suppressor cells are T  cells (1), macrophages/ 
monocytes (4), mast cells (4), or null cells (3, 5). An examination of these reports 
suggests that several different types of suppressor cells may exist in the neonatal 
spleen,  with  different suppressor/effector functions.  It appears  likely that  sup- 
pressor cells in the neonate play a role in the development of tolerance to foreign 
antigens  (33),  and  may also be  involved  in  the  maintainance  of immunologic 
balance between the mother and F1 fetal graft (34). The development of cloned 
suppressor cell lines may help elucidate the regulatory functions that contribute 
to the heightened susceptibility of tolerance induction in the neonate. 
SuITlnqaFy 
The establishment and characterization  of cloned natural suppressor (NS) cell 
lines derived from the spleen of neonatal  BALB/c mice are described.  Cloned 
NS cells suppress  the  mixed  leukocyte reaction  (MLR) between normal  adult 
responder and stimulator spleen cells with a 50-fold greater efficiency than fresh 
neonatal cells. Suppressive activity of both cells did not depend on the haplotype 
of the responder or stimulator cells, and was radioresistant.  Cloned NS cells did 
not inhibit the uptake of [3H]thymidine by HT-2 cells proliferating in response 
to  interleukin  2  (IL-2),  nor  the  in  vitro  secretion  of IL-1  by macrophages  in 
response to lipopolysaccharide. Several experiments indicated that absorption of 
IL-2 could not explain the suppression of the MLR by the NS cells in the range 
of cell numbers tested. The results suggest that NS cells may suppress the MLR 
by interfering with early stages of T  cell activation. The cell surface of a cloned 
NS cell line was examined using immunofluorescence staining, and was strongly 
positive for the Thy-l.2, Ly-5, and asialo-GM 1 antigens.  However, Lyt-1, Lyt-2, 
surface Ig,  IE, MAC-I, and Fc and C3 receptor markers were not detected. In 
addition, NS cells showed no cytolytic activity against the YAC-I target cell line. 
On  the basis of these findings,  cloned  NS cells do not appear  to be mature  T 
ceils,  B cells,  macrophages,  or  NK cells.  The  development of cloned  NS cells 
may be useful in determining the identity and mechanism of action of nonspecific 
suppressor cells in the neonatal spleen, and their role in neonatal  tolerance and 
maternal-fetal  relationships. SCHWADRON  ET  AL. 
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